Gazprom reached a new five year low on Friday. Despite possible repercussions on European markets, additional sanctions against Russia are still on the table if Russia fails to comply with a diplomatic solution. Further, European gas stores are reportedly full, indicating an atypically low reliance on Russian gas. Though it has been inching upwards today, Gazprom could quickly drop. The stock is up 0.32%.
Pfizer signed a deal with Merck over a new autoimmune therapy. The deal included an exclusivity clause, which would limit collaboration with other firms over drugs that fall within the same classes as the preliminary treatment. The move was initially negative for Pfizer as it crushes the likelihood of the AstraZeneca deal investors were still hopeful for. However, stocks could rise in the same manner as Merck’s did.
November 17, 2014 – Stock Market News
Gazprom reached a new five year low on Friday. Despite possible repercussions on European markets, additional sanctions against Russia are still on the table if Russia fails to comply with a diplomatic solution. Further, European gas stores are reportedly full, indicating an atypically low reliance on Russian gas. Though it has been inching upwards today, Gazprom could quickly drop. The stock is up 0.32%.
Pfizer signed a deal with Merck over a new autoimmune therapy. The deal included an exclusivity clause, which would limit collaboration with other firms over drugs that fall within the same classes as the preliminary treatment. The move was initially negative for Pfizer as it crushes the likelihood of the AstraZeneca deal investors were still hopeful for. However, stocks could rise in the same manner as Merck’s did.
Related Posts: